Send to

Choose Destination
Open Forum Infect Dis. 2018 Jun 4;5(6):ofy103. doi: 10.1093/ofid/ofy103. eCollection 2018 Jun.

Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).

Author information

Department of Medicine, Denver Health Medical Center, Denver, Colorado.
Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Department of Medicine, Northwestern University, Chicago, Illinois.
Department of Medicine, University of California San Francisco, San Francisco, California.


Hepatitis C virus (HCV) recurrence rates were similar between those with HCV/HIV co-infection (0.35/100 person-years) and HCV infection (0.42/100 person-years). Low rates of recurrence likely represent enrollment of an HIV population at low risk for recurrence. Care should be taken not to label all HCV/HIV co-infected patients as being at high risk for HCV recurrence.


HIV; direct acting antivirals; hepatitis C; recurrence

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center